{
  "meta": {
    "id": "test30",
    "title": "Chronic Lymphocytic Leukemia",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following statements is false regarding CLL ?",
      "options": [
        {
          "label": "A",
          "text": "It is primarily the disease of elderly",
          "correct": false
        },
        {
          "label": "B",
          "text": "More common in persons with Radiation exposure",
          "correct": true
        },
        {
          "label": "C",
          "text": "Most commonly diagnosed on routine blood work demonstrating an elevated lymphocyte count in asymptomatic individuals",
          "correct": false
        },
        {
          "label": "D",
          "text": "Therapy is usually reserved for patients with symptomatic disease",
          "correct": false
        }
      ],
      "correct_answer": "B. More common in persons with Radiation exposure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>More common in persons with Radiation exposure. CLL is primarily a disease of older adults with a median age at diagnosis is71 years. There is no definitive link between CLL and exposure to radiation.CLL is the only type of leukemia not related to radiation exposure. Most commonly occurs as an incidental diagnosis in asymptomatic individuals,although some patients present with symptoms and require therapy. Watchful waiting strategy is used for most patients with CLL with therapy reserved for patients with symptomatic disease.</p>\n<p><strong>Extraedge:</strong></p><p>Criteria for the Initiation of Therapy- Symptoms Indicating Need for Therapy in CLL Evidence of progressive marrow failure (worsening of anemia or thrombocytopenia not due to autoimmune destruction) Massive (\u22656 cm below costal margin), progressive, or symptomatic splenomegaly Massive (\u226510 cm), progressive, or symptomatic lymphadenopathy Progressive lymphocytosis with an increase of \u226550% over a 2-month period or lymphocyte doubling time <6 months Autoimmune anemia or thrombocytopenia not responsive to standard therapy Symptomatic or functional extranodal involvement Constitutional symptoms (one or more of the following: unintentional weight loss \u226510% over 6 months, significant fatigue, fevers \u2265100.5\u00b0C for 2+ weeks without infection, night sweats for >1 month without infection) .</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "17b1d007",
      "audio": ""
    },
    {
      "text": "There are 4 CLL patients in the intensive care unit. The first patient is having secondary malignancy developed as a result of CLL. The second patient is having hypogammaglobulinemia .The 3rd patient is having autoimmune complications. The 4th patient is having infection .Which of the following patients is considered to be at more risk ?",
      "options": [
        {
          "label": "A",
          "text": "Secondary malignancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypogammaglobulinemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Autoimmune complications",
          "correct": false
        },
        {
          "label": "D",
          "text": "Infection",
          "correct": true
        }
      ],
      "correct_answer": "D. Infection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Infection Complications of CLL include Infections,secondary cancers,autoimmune complications and transformation to a more aggressive clonally related lymphoma. Infections are leading cause of both disease related morbidity and death in patients with CLL owing to the immune dysfunction associated with the disease Patients are at risk for both typical and atypical infections Also most of the CLL therapies can increase the infection risk Hence it is the most dreaded complication and it is to be attended first</p>\n<p><strong>Highyeild:</strong></p><p>Transformation of CLL to aggressive lymphoma-Richter's Transformation</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A Secondary malignancy Multiple population based studies have shown that patients with CLL, elevates the risk to develop other cancers Even though the cancer is a risk, it is not as dreaded as development of infection Option: B Hypogammaglobulinemia Hypogammaglobulinemia is common in CLL and can be associated with significant risk of infection It is only a factor causing infection and it is not dreaded as the development of infection Option: C Autoimmune complications Autoimmune complications are frequent in CLL Most commonly these include autoimmune cytopenias mostly AIHA , but it is not as critical as infections</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f0789731",
      "audio": ""
    },
    {
      "text": "A 60 year old male has been noticing a firm non tender lump in the right side of the neck for 5 months.His CBC total leukocyte count of. 1,00,000 .Peripheral smear is as follows.Which of the following is suggestive of a good prognosis of the condition?",
      "options": [
        {
          "label": "A",
          "text": "Del 17 p",
          "correct": false
        },
        {
          "label": "B",
          "text": "Del 13q",
          "correct": true
        },
        {
          "label": "C",
          "text": "Del 11q",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trisomy 12",
          "correct": false
        }
      ],
      "correct_answer": "B. Del 13q",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1684542475094-QTDM077003IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Del 13q This points towards the diagnosis of chronic lymphocytic leukemia . The peripheral blood smear is showing small blue round cells,sparse cytoplasm,no nucleolus,and smudge cells. The diagnosis of typical CLL is made with B cell lymphocytosis greater than 5000 per microliter. CLL-Tumor arising from blood.Normally Naive B cell undergoes apoptosis and few of them enter lymphnode.Here there is defect in apoptosis there is monoclonal expansion of naive B cell leading to CLL. Normally with age there is B cell expansion. If the Monoclonal B Cell count<5000 cells/microliter- Monoclonal B cell Lymphocytosis Monoclonal B cell count>5000 cells/microliter\u2013CLL CD markers:CD19,CD20,CD21,CD22,CD79a ,CD79b . CLL B cell CD5,CD23 (very strongly expressed) Good prognosis -,Hypermutated Ig Heavy chain,Deletion 13q. Bad prognosis-Unmutated Ig heavy chain, high Zap 70,cd38. It is most common Leukemia. most common in males.Median age of survival is 70-72 years.</p>\n<p><strong>Highyeild:</strong></p><p>Markers of good prognosis Low Rai or Binet clinical stage Interstitial or nodular pattern of lymphocyte infiltration in marrow Lymphocyte doubling time >12 months CD38 negativity Mutated immunoglobulin Vh genes ZAP-70 negativity (low levels) Del 13q14 Markers of poor prognosis High Rai or Binet stages Diffuse pattern of lymphocyte marrow infiltration Lymphocyte doubling time <12 months CD38 positivity Unmutated immunoglobulin Vh genes ZAP-70 positivity (high levels) Del 11q23 17p-/p53 abnormalities TP53 dysfunction or increased expression Increased levels of TNF-alpha, beta-2 microglobulin, IL-6, IL-8, IL-10, LDH, VEGFR-2, CD20, and CD52</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b0c00c96",
      "audio": ""
    },
    {
      "text": "70 year old male Patient was undergoing routine general check up.on investigation his cbc: Which of the following statements is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Presence of anemia indicates mild disease in this case",
          "correct": false
        },
        {
          "label": "B",
          "text": "This condition is associated with warm antibody mediated AIHA",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pancytopenia is seen in the early stage of disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Zap 70 mutation is indicative of good prognosis",
          "correct": false
        }
      ],
      "correct_answer": "B. This condition is associated with warm antibody mediated AIHA",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>This condition is associated with warm antibody mediated AIHA Autoimmune complications are frequent in CLL. Most commonly, these include autoimmune cytopenias, the most common is autoimmune hemolytic anemia (AIHA),second most is immune thrombocytopenia (ITP). The Rai staging system is used staging Stage 0-Lymphocytosis Stage 1-Lymphocytosis + lymphadenopathy Stage 2-with hepatosplenomegaly Stage 3-with anemia Stage 4 -with pancytopenia. Stage 2,3,4 is suggestive of advanced disease.hence the option A and c are wrong.</p>\n<p><strong>Extraedge:</strong></p><p>Binet staging system for chronic lymphocytic leukemia Stage Description A Two or less lymphoid bearing areas enlarged* B Three or more lymphoid bearing areas enlarged* C Presence of anemia (hemoglobin <10 g/dL) or thrombocytopenia (platelet count <100,000/microL) *Five lymphoid bearing areas are possible: cervical, axillary, inguino-femoral, spleen, and liver.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e3778c21",
      "audio": ""
    },
    {
      "text": "Which of the following is not an indication for treatment of CLL? Progressive lymphadenopathy and splenomegaly. Progressive Bone Marrow Failure. Lymphocyte Doubling time is Low Extreme constitutional symptoms None of the above Select the correct answer from given below code:",
      "options": [
        {
          "label": "A",
          "text": "A, B",
          "correct": false
        },
        {
          "label": "B",
          "text": "C",
          "correct": false
        },
        {
          "label": "C",
          "text": "D",
          "correct": false
        },
        {
          "label": "D",
          "text": "E",
          "correct": true
        }
      ],
      "correct_answer": "D. E",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>E Criteria for the Initiation of Therapy- Symptoms Indicating Need for Therapy in CLL Evidence of progressive marrow failure ( worsening of anemia or thrombocytopenia not due to autoimmune destruction) Massive (\u22656 cm below costal margin), progressive, or symptomatic splenomegaly Massive (\u226510 cm), progressive, or symptomatic lymphadenopathy Progressive lymphocytosis with an increase of \u226550% over a 2-month period or lymphocyte doubling time <6 months Autoimmune anemia or thrombocytopenia not responsive to standard therapy Symptomatic or functional extranodal involvement Constitutional symptoms (one or more of the following: unintentional weight loss ?10% over 6 months, significant fatigue, fevers ?100.5\u00b0C for 2+ weeks without infection, night sweats for >1 month without infection).</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c1786c96",
      "audio": ""
    }
  ]
}